J. Goldman & CO LP Amicus Therapeutics, Inc. Transaction History

J. Goldman & CO LP

$3.21 Billion
Q3 2024

A detailed history of J. Goldman & CO LP transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, J. Goldman & CO LP holds 40,500 shares of FOLD stock, worth $396,494. This represents 0.01% of its overall portfolio holdings.

Number of Shares

40,500

Holding current value

$396,494

% of portfolio

0.01%

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$10.91 - $13.54 $1.78 Million - $2.2 Million	162,743 Added 72.36%	387,654 $4.3 Million
Q4 2022 Feb 14, 2023	BUY	$9.89 - $12.7 $2.22 Million - $2.86 Million	224,911 New	224,911 $2.75 Million
Q4 2021 Feb 14, 2022	BUY	$9.82 - $12.44 $1.27 Million - $1.61 Million	129,511 Added 312.56%	170,946 $1.97 Million
Q3 2021 Nov 15, 2021	SELL	$8.74 - $11.84 $1.05 Million - $1.43 Million	-120,511 Reduced 74.41%	41,435 $396,000
Q3 2019 Nov 14, 2019	BUY	$8.02 - $13.25 $1.3 Million - $2.15 Million	161,946 New	161,946 $1.3 Million
Q2 2018 Aug 14, 2018	SELL	$13.13 - $17.09 $1.07 Million - $1.39 Million	-81,618 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$13.76 - $17.12 $1.96 Million - $2.44 Million	-142,504 Reduced 63.58%	81,618 $1.23 Million
Q4 2017 Feb 14, 2018	BUY	$12.51 - $16.24 $257,981 - $334,901	20,622 Added 10.13%	224,122 $3.23 Million
Q3 2017 Nov 14, 2017	BUY	$11.74 - $15.78 $2.39 Million - $3.21 Million	203,500	203,500 $3.07 Million

Others Institutions Holding FOLD

# of Institutions

312

Shares Held

314M

Call Options Held

516K

Put Options Held

833K

Vanguard Group Inc Valley Forge, PA

28.8M
Shares

$282 Million
0.01% of portfolio
Perceptive Advisors LLC New York, NY

28.1M
Shares

$275 Million
7.83% of portfolio
Black Rock Inc. New York, NY

24.4M
Shares

$239 Million
0.01% of portfolio
Wellington Management Group LLP Boston, MA

24M
Shares

$235 Million
0.05% of portfolio
Avoro Capital Advisors LLC New York, NY

23.2M
Shares

$227 Million
3.72% of portfolio

View Full List

About AMICUS THERAPEUTICS, INC.

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.75B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

More about FOLD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of J. Goldman & CO LP, based on Form 13F filings with the SEC.

News

Stay updated on J. Goldman & CO LP with notifications on news.

Account